NASDAQ
Intellia Therapeutics, Inc. (NTLA) has a free cash flow growth of -69.17% as of Friday, May 29, 2026. This represents a 3512.07% decrease compared to its 12-month average of -1.92%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.